BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21331938)

  • 1. Pancreatic and hepatobiliary cancers.
    Buck AK; Herrmann K; Eckel F; Beer AJ
    Methods Mol Biol; 2011; 727():243-64. PubMed ID: 21331938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors.
    De Gaetano AM; Rufini V; Castaldi P; Gatto AM; Filograna L; Giordano A; Bonomo L
    Abdom Imaging; 2012 Dec; 37(6):983-1003. PubMed ID: 22527152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detectability of hypervascularity in early dynamic PET depends on tracer kinetics: 18 F-FDG versus 68 Ga-DOTATOC in hepatic NET metastasis.
    Sänger P; Schierz JH; Marlowe RJ; Freesmeyer M
    Liver Int; 2014 Jan; 34(1):161. PubMed ID: 23663248
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
    Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH
    Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDG PET/CT in Pancreatic and Hepatobiliary Carcinomas: Value to Patient Management and Patient Outcomes.
    Parikh U; Marcus C; Sarangi R; Taghipour M; Subramaniam RM
    PET Clin; 2015 Jul; 10(3):327-43. PubMed ID: 26099670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography in malignancies of the liver, pancreas and biliary tract - indications and potential pitfalls.
    Ansari D; Keussen I; Andersson R
    Scand J Gastroenterol; 2013 Mar; 48(3):259-65. PubMed ID: 23148675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
    Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ
    Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [[18F]-FDG-PET in the diagnostics of gastrointestinal tumors].
    Buchmann I; Ganten TM; Haberkorn U
    Z Gastroenterol; 2008 Apr; 46(4):367-75. PubMed ID: 18393156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
    Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
    J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.
    Putzer D; Gabriel M; Henninger B; Kendler D; Uprimny C; Dobrozemsky G; Decristoforo C; Bale RJ; Jaschke W; Virgolini IJ
    J Nucl Med; 2009 Aug; 50(8):1214-21. PubMed ID: 19617343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
    Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S
    Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nuclear medical diagnostics for liver tumors].
    Buck AK; Stollfuss JC; Stahl A; Beer AJ; Meisetschläger G; Schwaiger M
    Internist (Berl); 2007 Jan; 48(1):21-4, 26-9. PubMed ID: 17195061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of FDG-PET in the evaluation and staging of hepatocellular carcinoma with comparison of tumor size, AFP level, and histologic grade.
    Wolfort RM; Papillion PW; Turnage RH; Lillien DL; Ramaswamy MR; Zibari GB
    Int Surg; 2010; 95(1):67-75. PubMed ID: 20480845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Combined 68Ga-DOTATOC and 18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors: Implications for Managing Surgical Decisions.
    Cingarlini S; Ortolani S; Salgarello M; Butturini G; Malpaga A; Malfatti V; DʼOnofrio M; Davì MV; Vallerio P; Ruzzenente A; Capelli P; Citton E; Grego E; Trentin C; De Robertis R; Scarpa A; Bassi C; Tortora G
    Pancreas; 2017 Jan; 46(1):42-47. PubMed ID: 27906872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
    Ho CL; Chen S; Yeung DW; Cheng TK
    J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of positive
    Zilli A; Fanetti I; Conte D; Massironi S
    Clin Imaging; 2018; 49():156-158. PubMed ID: 29529451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L-dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients.
    Putzer D; Gabriel M; Kendler D; Henninger B; Knoflach M; Kroiss A; Vonguggenberg E; Warwitz B; Virgolini IJ
    Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):68-75. PubMed ID: 20168288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility of (18)F-fluorodeoxyglucose positron-emission tomography for preoperative evaluation of biliary tract cancer.
    Yamada I; Ajiki T; Ueno K; Sawa H; Otsubo I; Yoshida Y; Shinzeki M; Toyama H; Matsumoto I; Fukumoto T; Nakao A; Kotani J; Ku Y
    Anticancer Res; 2012 Nov; 32(11):5105-10. PubMed ID: 23155288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.